In december 2019, SARS-CoV2 and its clinical manifestations, COVID-19, appeared in China and caused a pandemic. It led decision makers to prioritize emergency and intensive care dedicated to infection management. Other conditions, such as cancer screening, diagnosis, and treatment, may have been delayed during the containment period. Consequences of this "distraction effect" are being.
Quantitative monthly data were analyzed from January 1, 2019 to May 31, 2020 in two French
tertiary care center (University Hospital and Godinot Cancer Institute in Reims) and in a
third center in the French epicenter (Colmar hospital). Oncologic activity indicators were
extracted using oncologic electronic file, International Statistical Classification of
Diseases and Related Health Problems, Tenth Revision (ICD-10) and nation-wide procedure codes
(CCAM). The monthly number of different steps of oncology care pathway (screening, diagnosis
and treatment) were collected: faecal immunochemical testing (FIT), mammography,
histopathological and biomolecular/genetics analysis, nuclear medicine imaging, oncogeriatric
evaluations, multidisciplinary tumor board meetings and files reviewed by meeting including
first presentations, given personalized care program, medical announcement and reformulation
nursing consultations, inserted central venous catheters, chemotherapy prepared and
administered in chemotherapy day care, carcinologic surgeries and radiotherapy courses.
Other: data record
Data record on registers without medical files
Inclusion Criteria:
- Every adult patient entering an oncology care pathway between 01/01/2019 and
31/12/2020
Exclusion Criteria:
- <18 yo
Chu Reims
Reims, France